Mannatech Secures Its 100th Global Patent

This week Mannatech is celebrating a major feat of research and development. The nutrition company has received its 100th patent, issued in Korea for its PhytoMatrix dietary supplement formulation.

While industry giants such as Amway and Mary Kay—with more than 1,100 and 800 patents, respectively—have built up large patent portfolios, Mannatech is an aberration among mid-sized companies both in direct selling and in the nutritional supplement industry. Averaging nearly five patent awards per year, Mannatech has outpaced many larger, older brands.

Mannatech guards its core technology and formulations to keep its products from becoming “mere commodities” in the market, says Dr. Rob Sinnott, CEO and Chief Science Officer. “We believe this approach helps our Associates to build a successful business in major global markets around the world.”

Mannatech’s comprehensive quality assurance program complies with the U.S. Food and Drug Administration’s current Good Manufacturing Practices. Many of the company’s products have also attained third-party certification through NSF International, which imposes rigorous testing and compliance standards. In addition to its PhytoMatrix product, Mannatech has patented technology pertaining to its Ambrotose, Ambrotose AO and GI-ProBalance formulations.

Advertisements

About Direct Selling News
Direct Selling News Magazine has been serving direct selling and network marketing executives since 2004. Each issue of Direct Selling News offers content on topics that shape the dynamics of our industry.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: